Adme-Enabling Technologies in Drug Design and Development
Editat de Donglu Zhang, Sekhar Surapanenien Limba Engleză Hardback – 30 apr 2012
Preț: 1191.04 lei
Preț vechi: 1308.83 lei
-9%
Puncte Express: 1787
Carte tipărită la comandă
Livrare economică 08-22 iunie
Specificații
ISBN-13: 9780470542781
ISBN-10: 0470542780
Pagini: 624
Dimensiuni: 221 x 286 x 38 mm
Greutate: 1.8 kg
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 0470542780
Pagini: 624
Dimensiuni: 221 x 286 x 38 mm
Greutate: 1.8 kg
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Scientists in the pharmaceutical industry, medicine, pre–clinical drug discovery and development researchers, chemists and clinical researchers; academic drug metabolism experts; new industry recruits, toxicology, bioanalytical researchers.Notă biografică
Donglu Zhang, PhD, is a Principal Scientist in Pharmaceutical Candidate Optimization at Bristol-Myers Squibb in Princeton, New Jersey. He has published seventy peer-reviewed articles, codiscovered the Mass Defect Filtering technique, and coedited two books. Sekhar Surapaneni, PhD, is Director, DMPK, at Celgene Corporation in New Jersey. He has published extensively in peer-reviewed journals and is a member of ISSX and ACS.
Descriere
This book comprehensively covers the state-of-the-art and cutting-edge technologies in an integrated fashion for applications in ADME studies of small molecular drugs. Each chapter provides descriptions of the technologies, application scope and limitations, optimal conditions for intended results, protocols, case studies, and future developments.